The NHS has struck a deal for a life-saving treatment, reportedly the most expensive drug in the world, that will offer babies and young children with a rare and fatal genetic disease the prospect of a normal life, the health service chief executive has announced today. The revolutionary gene therapy treatment is known by its […]
Thousands of lung cancer patients in England will be fast-tracked a ground-breaking new drug which can significantly reduce the risk of cancer returning, thanks to a deal brokered by NHS England. The MHRA has now approved the effective therapy, atezolizumab, to treat non-small cell lung cancer (NSCLC), with more than 850 patients in England expected […]
Thousands of children and young people will receive a pioneering treatment for peanut allergy after NHS England secured the first deal of its kind in Europe. The treatment, known as Palforzia, helps to reduce the severity of reactions to peanuts – including anaphylaxis – making family holidays abroad, birthday parties, and Christmas treats possible for […]
A five-month old baby has become the first patient to receive a potentially life-saving drug on the NHS that can prevent paralysis and prolong the lives of children with Spinal Muscular Atrophy (SMA). Arthur Morgan, who was diagnosed with SMA earlier this month, received the one-off gene therapy at Evelina London Children’s Hospital on May […]
A world-leading treatment that halves the risk of lung cancer patients suffering a return of the disease after undergoing treatment, is to be rolled out by NHS England. In a trial of the drug – the first of its kind – around nine out of ten patients treated, remained alive and disease-free after two years […]
NHS England has today announced it has secured a definitive agreement with Vertex Pharmaceuticals to make available all three of their UK-licensed cystic fibrosis medicines. This means NHS patients will now have full access to Orkambi, Symkevi and Kalydeco, and around 5000 people may now take up these treatments. There is no cap on patient numbers, and each and every patient in England who […]
NHS England is to fund a life changing treatment for thousands of people with severe Haemophilia, which will dramatically cut their risk of life-threatening bleeds and reduce treatment time. The new treatment is part of a package of measures set out in the NHS Long Term Plan which will save lives through access to the […]
People living with brain and nerve conditions like Parkinson’s could benefit from quicker diagnosis and better coordinated care as part of a new NHS initiative, which is also set to free up millions of pounds to reinvest in patient care. NHS experts have joined forces with seven leading charities to produce a toolkit that will […]
NHS England will provide a promising new treatment which can prolong the lives of children with a rare genetic condition after negotiating a deal with the manufacturer. Nusinersen, also called Spinraza and made by Biogen, is the first treatment that targets the underlying cause of spinal muscular atrophy (SMA). The condition affects the nerves in […]
New places for the PrEP Impact Trial will now start to be released following agreement at the PrEP Oversight Board. Implementation of the PrEP Impact trial has been a huge success with over 11,500 participants already enrolled in this important HIV prevention measure. With the speed of recruitment and need for PrEP significantly exceeding initial […]